AR061351A1 - Composicion de carbamato de bencimidazol - Google Patents

Composicion de carbamato de bencimidazol

Info

Publication number
AR061351A1
AR061351A1 ARP070102576A ARP070102576A AR061351A1 AR 061351 A1 AR061351 A1 AR 061351A1 AR P070102576 A ARP070102576 A AR P070102576A AR P070102576 A ARP070102576 A AR P070102576A AR 061351 A1 AR061351 A1 AR 061351A1
Authority
AR
Argentina
Prior art keywords
composition
bencimidazol
carbamate composition
prepare
parasites
Prior art date
Application number
ARP070102576A
Other languages
English (en)
Inventor
Elisabeth Benedicte Daniele Deschamps
Mark Allan
Carsten Schmidt
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of AR061351A1 publication Critical patent/AR061351A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composicion farmacéutica para la administracion en el agua de bebida, que comprende partículas de carbamato de bencimidazol que tienen un tamano de partícula promedio eficaz inferior a 450 nm y un surfactante de tipo Tween; un método para preparar la composicion; uso de la composicion para preparar un medicamento para controlar los parásitos; y un método para proteger a un animal de una infeccion parasitaria.
ARP070102576A 2006-06-14 2007-06-13 Composicion de carbamato de bencimidazol AR061351A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81392806P 2006-06-14 2006-06-14
EP06115495 2006-06-14

Publications (1)

Publication Number Publication Date
AR061351A1 true AR061351A1 (es) 2008-08-20

Family

ID=38366726

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102576A AR061351A1 (es) 2006-06-14 2007-06-13 Composicion de carbamato de bencimidazol

Country Status (9)

Country Link
US (1) US8777134B2 (es)
EP (1) EP2037914B1 (es)
JP (1) JP5126754B2 (es)
KR (1) KR101403135B1 (es)
AR (1) AR061351A1 (es)
CA (1) CA2660647C (es)
MX (1) MX2008015764A (es)
PL (1) PL2037914T3 (es)
WO (1) WO2007144362A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419996B2 (en) * 2003-08-13 2008-09-02 The University Of Houston Parenteral and oral formulations of benzimidazoles
EP2037914B1 (en) 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
WO2010011289A2 (en) * 2008-07-24 2010-01-28 University Of Houston Parenteral and oral formulations of benzimidazoles
BRPI0804639A2 (pt) * 2008-10-23 2010-07-20 Formil Veterinaria Ltda processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
US10829649B2 (en) 2018-04-20 2020-11-10 Redjak, L.L.C. Methods and coatings for protecting surfaces from bio-fouling species
US10689527B2 (en) 2018-04-20 2020-06-23 Redjak, L.L.C Methods and coatings for protecting surfaces from bio-fouling species
US10519327B2 (en) 2018-04-20 2019-12-31 Redjak, L.L.C. Methods and coatings for protecting surfaces from bio-fouling species
BR102020021181A2 (pt) * 2020-10-16 2022-04-26 Ipanema Industria De Produtos Veterinarios Ltda Microssuspensão contra parasitas e método para sua obtenção
EP4389116A1 (en) 2022-12-23 2024-06-26 Dechra Ltd Pharmaceutical aqueous flubendazole suspension

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE666795A (es) 1964-08-04 1966-01-13
US3480642A (en) 1967-03-22 1969-11-25 Smithkline Corp Process for producing 2-carbalkoxyaminobenzimidazoles
US3657267A (en) 1969-06-20 1972-04-18 Janssen Pharmaceutica Nv Benzimidazole carbamates
BE793358A (fr) 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
BE795360A (fr) 1972-02-16 1973-08-13 Merck & Co Inc Benzimidazoles phosphoryles
US3929821A (en) 1972-12-29 1975-12-30 Syntex Inc 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives
IN142490B (es) 1974-05-15 1977-07-16 Bayer Ag
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
FR2336931A1 (fr) 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US4348406A (en) 1980-10-20 1982-09-07 Schering Corporation Novel guanidine derivatives
EP0093497A3 (en) * 1982-04-30 1985-03-20 Smith Kline & French Laboratories Limited Anthelmintic treatment
DE3247615A1 (de) 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9115273D0 (en) 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
SE9103776D0 (sv) 1991-12-19 1991-12-19 Astra Ab New compounds
US5538989A (en) 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
AU698431B2 (en) * 1993-12-13 1998-10-29 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
IES66993B2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd A process
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
WO2000050009A1 (en) 1999-02-26 2000-08-31 Idexx Laboratories, Inc. Methods for administering pharmacologically active compounds to vertebrates
KR100702540B1 (ko) * 1999-09-03 2007-04-04 얀센 파마슈티카 엔.브이. 수 분배 시스템을 통해 표적 동물에 수-불용성 약물을투여하기 위한 수의학적 제제
MXPA03009021A (es) 2001-04-03 2004-02-12 Schering Corp Composicion antifungal con biodisponibilidad aumentada.
JP4616556B2 (ja) 2002-01-16 2011-01-19 インターベツト・インターナシヨナル・ベー・ベー ポリ酒石酸エステル組成物
PL1913009T3 (pl) 2005-07-28 2010-10-29 Intervet Int Bv Nowe (tio)karbaminiany benzimidazolu o działaniu przeciwpasożytniczym i sposób ich wytwarzania
JP5342239B2 (ja) 2005-12-06 2013-11-13 ゾエティス・ダブリュー・エルエルシー ベンジイミダゾール非水性組成物
EP2037914B1 (en) 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
BRPI0804639A2 (pt) 2008-10-23 2010-07-20 Formil Veterinaria Ltda processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água

Also Published As

Publication number Publication date
US20120213830A1 (en) 2012-08-23
MX2008015764A (es) 2009-01-07
WO2007144362A1 (en) 2007-12-21
JP5126754B2 (ja) 2013-01-23
KR101403135B1 (ko) 2014-06-19
EP2037914A1 (en) 2009-03-25
EP2037914B1 (en) 2013-10-23
US8777134B2 (en) 2014-07-15
JP2009539933A (ja) 2009-11-19
CA2660647A1 (en) 2007-12-21
KR20090023622A (ko) 2009-03-05
PL2037914T3 (pl) 2014-04-30
CA2660647C (en) 2015-07-28

Similar Documents

Publication Publication Date Title
AR061351A1 (es) Composicion de carbamato de bencimidazol
CO6321225A2 (es) Particulas portadoras sólidas para mejorar la procesabilidad de un agente farmacéutico
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
AR051969A1 (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y el manejo de lesiones del sistema nervioso central
ECSP088560A (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
AR048431A1 (es) Formulaciones galenicas de compuestos organicos
AR063940A1 (es) Formulaciones de posaconazol nanoparticulado
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
CL2008001297A1 (es) N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer.
AR054227A1 (es) Composicion de principios activos
UY29005A1 (es) Composiciones plaguicidas líquidas.-
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
PL410258A1 (pl) Weterynaryjne doustne kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne, sposoby i zastosowania je obejmujące
AR080662A1 (es) Forma de dosis oral solida con contenido de nanoparticulas y proceso de formulacion de la misma utilizando gelatina de pescado
PE20100740A1 (es) Formulacion farmaceutica de rapida disolucion que comprende clorhidrato de vardenafil trihidrato
AR054595A1 (es) Formulaciones/composiciones farmaceuticas de guanfacina apropiadas para forma de administracion diaria en una unica dosis
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
ECSP11011199A (es) Formulación de depósito de octreotida con niveles de exposición constantemente altos
AR075180A1 (es) Formulaciones orales solidas de una pirido-pirimidinona
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal